X-14857956-TAATAAATA-TAATAAATAAATA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001018113.3(FANCB):c.1105-6_1105-3dupTATT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00259 in 1,065,970 control chromosomes in the GnomAD database, including 25 homozygotes. There are 597 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0098 ( 19 hom., 246 hem., cov: 22)
Exomes 𝑓: 0.0018 ( 6 hom. 351 hem. )
Consequence
FANCB
NM_001018113.3 splice_region, intron
NM_001018113.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.218
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-14857956-T-TAATA is Benign according to our data. Variant chrX-14857956-T-TAATA is described in ClinVar as [Likely_benign]. Clinvar id is 167060.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00976 (1091/111735) while in subpopulation AFR AF= 0.0307 (942/30696). AF 95% confidence interval is 0.0291. There are 19 homozygotes in gnomad4. There are 246 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FANCB | NM_001018113.3 | c.1105-6_1105-3dupTATT | splice_region_variant, intron_variant | ENST00000650831.1 | NP_001018123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FANCB | ENST00000650831.1 | c.1105-6_1105-3dupTATT | splice_region_variant, intron_variant | NM_001018113.3 | ENSP00000498215.1 |
Frequencies
GnomAD3 genomes AF: 0.00975 AC: 1089AN: 111688Hom.: 19 Cov.: 22 AF XY: 0.00725 AC XY: 246AN XY: 33946
GnomAD3 genomes
AF:
AC:
1089
AN:
111688
Hom.:
Cov.:
22
AF XY:
AC XY:
246
AN XY:
33946
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00250 AC: 444AN: 177339Hom.: 2 AF XY: 0.00117 AC XY: 74AN XY: 63079
GnomAD3 exomes
AF:
AC:
444
AN:
177339
Hom.:
AF XY:
AC XY:
74
AN XY:
63079
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00175 AC: 1670AN: 954235Hom.: 6 Cov.: 17 AF XY: 0.00132 AC XY: 351AN XY: 266053
GnomAD4 exome
AF:
AC:
1670
AN:
954235
Hom.:
Cov.:
17
AF XY:
AC XY:
351
AN XY:
266053
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00976 AC: 1091AN: 111735Hom.: 19 Cov.: 22 AF XY: 0.00723 AC XY: 246AN XY: 34003
GnomAD4 genome
AF:
AC:
1091
AN:
111735
Hom.:
Cov.:
22
AF XY:
AC XY:
246
AN XY:
34003
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Eurofins Ntd Llc (ga) | Mar 19, 2014 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 16, 2016 | - - |
Fanconi anemia Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Sep 29, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2014 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at